Major Depressive Disorder |18+| Outpatient | Earn Up to $925
Segal Trials is currently conducting an outpatient Psychedelic clinical research study evaluating the safety and efficacy of psilocybin for patients with Depression.
Participants may qualify if they are:
- Adults 18+ years old
- Diagnosed or experience symptoms of Depression
- Major Depressive Episode for at least 60 days
- Study length: Up to 64 weeks
Participants who qualify may receive:
- Study-related exams & lab work – at no cost
- Available transportation
- No insurance is necessary
- Compensation up to $925 if qualified